The leading global voice
We play a major role in bringing the CV community together to drive transformational change.
Together we are stronger
By 2025, our aim is to reduce premature deaths from CVD by at least 25%.
Join the fight
Become a WHF member and help us to build global commitment to address cardiovascular health at the policy level.
We convene and connect our members
To share science, best practice and resources, acting as a global thought leader and catalyst for positive change.
Celebrate World Heart Day
The biggest global awareness-raising campaign for CVD.
Attend the Congress
Join world leaders in heart health, share ideas, network with specialists.
Advocating for heart health
We lead the global advocacy effort for action to prevent, control and reduce the global burden of CVD.
All our programmes and partnerships are aimed at creating awareness of CVD as a priority issue across the globe.
Find out more about our and our members' work around the world.
Explore everything from toolkits, videos and infographics, to policy reports, factsheets and more.
The World Heart Federation will be attending the 68th World Health Assembly (WHA) from 18-26 May in Geneva. The agenda for this WHA promises to be particularly relevant for cardiovascular disease (CVD), as Agenda Item 13 is dedicated exclusively to ‘Non-communicable Diseases’.
To advocate, raise awareness and share best practice for CVD prevention and control, the World Heart Federation will be holding three side events during WHA:
Sunday 17th May: ‘WHF Roadmap Launch: Raised Blood Pressure’
12:00-14:00, Grenier Room, Domaine des Penthes, Geneva
The World Heart Federation has created a practical roadmap that summarizes potential roadblocks (at different health-system levels) along the care pathway for patients with, or at-risk of developing, hypertension. This Roadmap presents potential solutions to overcoming these roadblocks and includes case studies from low-, middle-, and high-income countries, and identifies three key areas for action: opportunistic screening, improved treatment and education. Please contact us to request an invitation.
Monday 18th May: ‘Marginalized in their Teens: Rheumatic Heart Disease in Adolescents’
12:30-14:00, Ballroom B, InterContinental Hotel, Geneva
Rheumatic heart disease is an NCD (non-communicable disease) of the poor, which kills and disables millions of adolescents in the world’s most marginalized communities. This preventable disease (already practically eliminated in Europe and the Americas), disproportionately affects adolescents in Sub-Saharan Africa, the Pacific, and the Asian regions.
This meeting, which is open to health workers, clinicians, global health professionals and stakeholders from all development sectors, seeks to address why RHD progress has been so insufficient and uneven, and strategise ways that the disease can be integrated into existing global development frameworks. All are welcome to attend this event, you can register here.
Tuesday 19th May: ‘What is Good for the Heart, is Good for the Brain’
18:00-20:00, Geneva Press Club, Geneva
Co-hosted by Alzheimer’s Disease International, the NCD Alliance and the World Heart Federation
There is increasing evidence that major risk factors of NCDs and heart diseases also increase the risk of getting dementia in later life. Several recent studies have identified cardiovascular risk factors like smoking, mid-life hypertension and diabetes as important risk factors for dementia. This side meeting aims to address these connections in depth, focusing on the scientific research, behavioural nature of the shared risk factors, and the need to devise strong public health messaging that supports both cardiovascular and dementia health education. Having established the link, the meeting will set out an integrated approach to tackling the shared risk factors, informed by the patient experience. Please contact us at email@example.com to request an invitation.
The Argentine Society and Argentine Foundation of Cardiology meet with the Health Ministry of Buenos Aires
WHF Cholesterol Roadmap presented at the Latin American Cholesterol Summit in Mexico
Symposium on 'Fixed-dose combinations for CVD and hypertension' at the London School of Hygiene & Tropical Medicine